Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The Lovesac Company to Host Investor Day
-
Marquette National Corporation Declares a Dividend of $0.28 per Share
-
Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024
-
Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
Nicholas Wealth Announces $100,000,000 in AUM for $FIAX ETF
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Transactions in connection with share buyback programme
-
Endeavour Silver provides a Q3 2024 construction progress update on Terronera; the surface construction progress has reached 77% completion
-
BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
-
Bilibili Inc. Announces Repurchase Right Notification for 0.50% Convertible Senior Notes due 2026
-
Hyperscale Data Announces Twenty-Eight Consecutive Monthly Cash Dividend Payments Timely Paid for Series D Preferred Stock
-
Parsons to Acquire BCC Engineering
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
Correction: HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
Sandy Spring Bancorp Reports Third Quarter Earnings of $16.2 Million
-
XO Strengthens World's Largest Private Aviation Network and Boosts Instant Booking Options by Over 55%
-
Eclipse Zenoh 1.0.0 Debuts, Redefining Connectivity for Robotics and Automotive
-
Nearly 80% of U.S. Adults Say They're Worried About The Economy
-
Highwoods Declares Quarterly Dividends
-
Tower Semiconductor Announces Third Quarter 2024 Financial Results and Conference Call
-
Grab to Announce Third Quarter 2024 Results on November 12, 2024
-
Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers
-
CoachNow by Golf Genius Announces New Low-Cost Membership Option
-
SunHydrogen on Track for 1m² Pilot Demonstration of its Green Hydrogen Panels
-
Nearly 80% of U.S. Adults Say They're Worried About The Economy
-
XO Strengthens World's Largest Private Aviation Network and Boosts Instant Booking Options by Over 55%
-
China Eastern Airlines joins 2024 ESG Global Leaders Conference
-
Q3, 2024
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 18 10 2024] - (CGWL)
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 18 10 2024] - (CGWL)
-
Form 8.3 - [ECKOH PLC - 18 10 2024] - (CGWL)
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Man Group PLC : Form 8.3 - AngloGold Ashanti plc
-
Form 8.5 (EPT/RI)
-
Net Asset Value(s)
-
Novo Nordisk A/S: Oral semaglutide demonstrates a 14% reduction in risk of major adverse cardiovascular events in adults with type 2 diabetes in the SOUL trial
-
Man Group PLC : Form 8.3 - TI Fluid Systems plc
-
Man Group PLC : Form 8.3 - International Paper Company
-
Debtor distribution data (CK92) - Totalkredit A/S
-
Debtor distribution data (CK92) - Nykredit Realkredit A/S
-
Financial calendar
-
KFSHRC Launches Mobile Stroke Unit to Accelerate Patient Treatment
-
Gilat to Report Third Quarter 2024 Results on Wednesday, November 13th
-
Alm. Brand A/S – Weekly report on share buybacks
-
Growing Opportunities for Canadian Farmers to Sustainably Manage Agricultural Waste in 2024
-
BlackRock® Canada Announces October Cash Distributions for the iShares® ETFs
-
Golar LNG Limited – Q3 2024 results presentation
-
Leil Storage: Green File Storage for Africa
